JPRN-UMIN000030851已完成未知
Comparative study of various DOACs for atrial fibrillation after cardiac surgery(prospective observation research) - Comparative study of various DOACs for atrial fibrillation after cardiac surgery
ihon University0 个研究点目标入组 135 人开始时间: 2018年1月17日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 135
研究概览
简要总结
Results: Patients were treated with apixaban (n = 31), edoxaban (n = 87), and rivarox- aban (n = 17). Major bleeding (p = 0.011) and gastrointestinal (GI) bleeding (p = 0.047) were signi cantly more frequent in the rivaroxaban group. Stroke was observed in one rivaroxaban group patient and none in the other two groups.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •valve replacement surgery Doctor's decision not to register to this regimen
研究者
相似试验
Unknown
4 期
Rivaroxaban in Patients With Atrial Fibrillation and Coronary Artery Disease Undergoing Percutaneous Coronary InterventionAtrial FibrillationNCT02334254Beijing Anzhen Hospital420
已完成
2 期
Apixaban Versus Warfarin for the Management of Post-operative Atrial FibrillationCoronary Artery Bypass GraftingPostoperative Atrial FibrilationSystemic EmbolismStrokeDeep Venous ThrombosisNCT02889562Sanford Health56
已完成
不适用
Comparison of Two Doses of Edoxaban Using Different Tests (Assays) and Clinical OutcomesAtrial FibrillationNCT02964949Daiichi Sankyo607
已完成
4 期
Rivaroxaban Versus Warfarin in the Evaluation of Progression of Coronary CalciumAtherosclerosisNCT02376010Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center110
招募中
2 期
Efficacy and Safety of Edoxaban in Patients With Atrial Fibrillation and Mitral StenosisMitral Valve StenosisSystemic EmbolismAtrial FibrillationStrokeNCT05540587Sung-Hwan Kim240